FDA requires prepaid mail-back envelopes for opioid analgesics
April 5, 2023Medical Communications
The FDA has announced that it will require opioid analgesic manufacturers to provide prepaid mail-back envelopes in outpatient pharmacies and …
Phlo acquires Truepill UK in landmark digital pharmacy consolidation
April 4, 2023Business Services
Glasgow, UK. Phlo Technologies UK digital pharmacy leaders, have today announced their acquisition of the UK arm of US-based healthcare …
Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO
April 4, 2023Business Services
Cambridge, UK, 04 April 2023 – Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company dedicated to resolving …
Recipharm bolsters senior leadership team with appointment of Joaquim Mascaro as Chief Financial Officer
April 4, 2023Business Services
Global contract development and manufacturing organisation (CDMO) Recipharm, has announced the appointment of Joaquim Mascaro as Chief Financial Officer.
Optibrium Appoints Computational Modelling Expert, Dr Hamed Tabatabaei Ghomi as Head of Research
April 4, 2023Business Services
Appointment will lead research strategy to apply the latest scientific innovations to Optibrium’s computational and AI drug discovery technologies Hamed …
Landmark data published on successful NTCD-M3 gut colonisation after fidaxomicin administration
April 4, 2023Business Services
Brighton, United Kingdom – 4 April 2023 – Destiny Pharma (AIM: DEST), a clinical stage innovative biotechnology company focused on …
PHARMANOVIA RECEIVES SBTi APPROVAL FOR NET ZERO EMISSION TARGETS
April 4, 2023Business Services
Basildon, UK, 3 April 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already established …
Ingenza appoints Steve Jones as its new Chief Financial Officer
April 4, 2023Business Services Ingenza
Ingenza appoints Steve Jones as its new Chief Financial Officer
Orbit Discovery and Evergreen Discovery collaborate to discover peptides for targeting radiopharmaceuticals
April 4, 2023Business Services
New Jersey, USA, and Oxford, UK, 3rd April 2023: Evergreen Discovery (Evergreen), a leading radiopharmaceutical drug development company with a …
Vertex Pharmaceuticals and CRISPR Therapeutics submit FDA rolling Biologics License Applications for gene editing-based medicine
April 4, 2023Research and Development
US-based Vertex Pharmaceuticals and Swiss CRISPR Therapeutics have announced the completion of their rolling Biologics License Applications (BLAs) to the …
FDA publishes report stating Global Pharma’s eye drops broke safety norms
April 4, 2023Medical Communications
The FDA has published a report revealing that Global Pharma’s plant in India’s Chennai city failed to achieve safety norms …
InnoCare announced first subject dosed in clinical trial of novel targeted protein degrader ICP-490
April 4, 2023Medical Communications
InnoCare has announced that the first subject has been dosed in its clinical trial of its novel targeted protein degrader …
Merck receives FDA approval for Keytruda in combination with Padcev to treat bladder cancer
April 4, 2023Medical Communications
Merck (known as MSD globally) has announced that it has received FDA approval for Keytruda in combination with Padcev for …
Théa Open Innovation and Galimedix announce partnership for development and commercialisation of GAL-101
April 3, 2023Sales and Marketing
Théa Open Innovation (TOI) and Galimedix have announced that they have signed a licensing agreement granting TOI exclusive rights for …
aVaxziPen announces positive data for multiple diseases with novel needle-free vaccine
April 3, 2023Research and Development
aVaxziPen, a biotech company focusing on the development of a novel needle-free vaccine delivery platform, has announced that it will …
Pixium Vision’s Prima System granted FDA Breakthrough Device Designation
April 3, 2023Medical Communications
French bioelectronics company Pixium Vision has been granted Breakthrough Device Designation by the FDA for its Prima System. Prima …
AstraZeneca’s NMOSD treatment recommended marketing authorisation by CHMP
April 3, 2023Medical Communications
Pharma giant AstraZeneca has been given a recommendation by the EU’s Committee for Medicinal Products (CHMP) for marketing authorisation for …
CrestOptics launches CICERO system to provide all-in-one solution for widefield and spinning disk confocal microscopy
April 3, 2023Business Services
Rome, IT, 03 April, 2023: CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and …
Sequana Medical announces submission of Investigational New Drug (IND) application for DSR® 2.0 for treatment of congestive heart failure
April 3, 2023Business Services
Ghent, Belgium – 03 April 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana
Novo Nordisk Foundation to support crucial education of health professionals in India and East Africa with up to DKK 1bn (USD 140m)
April 3, 2023Business Services
Lack of access to qualified health personnel combined with an alarming prevalence of noncommunicable diseases (NCDs) such as cardiometabolic diseases …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
